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Objectives: The approach of the diabetes register named DIAREG is to display the 
health care reality of patients with type 2 diabetes (T2D) in Germany. In comparison 
to other existing diabetes registries, DIAREG analyses patient-reported outcomes 
(PRO) in order to illustrate patient reported quality of life (QoL). MethOds: In July 
2013 DIAREG was started including retrospective as well as prospective data from 
over 100 office based physicians (general practitioner and diabetologists). DIAREG 
analysis is based on 6 different PRO: generic quality of life questionnaire (SF-36); 
audit of diabetes–dependent quality of life (ADDQoL); diabetes treatment satisfac-
tion questionnaire (DTSQ); impact of weight quality of life (IWQoL-Lite); Center of 
Epidemiological Studies Depression Scale (CES-D) and WHO five well being index 
(WHO-5). Results: By June 2015 more than 2,000 T2D patients were included in the 
register, involving an observation period of 22 months. Within this time frame PRO 
of more than 300 patients were completed. The mean age of T2D patients was 68.5 
years, whereas 48% of the patient population was older than 70 years. According to 
a subgroup analysis of 1,646 patients, 16% of the patients were recruited by office-
based diabetologists and the majority of 84% by primary care physicians. About 20% 
of these patients had their therapy changed within the last year due to inadequate 
HbA1C control. An adjustment of the current therapy was conducted at 81%, a 
change of the therapy at 46%. Main focus of the physicians for changing the therapy 
pattern was the decrease of the HbA1C. Based on this platform, further evaluation 
on QoL will be started. cOnclusiOns: In conclusion, DIAREG shows the treatment 
reality from the patient and physician perspective and will therefore describe the 
health care situation and QoL of diabetes patients in Germany.
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Objectives: To develop a specific questionnaire to assess the impact of hypo-
glycemia on the health-related quality of life (HRQoL) of patients with type 2 dia-
betes mellitus (T2DM). MethOds: A first version of the QolHypo questionnaire 
was obtained from a literature review and focus groups with patients and physi-
cians. QolHypo consisted of 37 specific items about the impact of hypoglycemia on 
HRQoL with 5 response categories. The final version was obtained by item reduction 
methods: floor and ceiling effects and Rasch analysis. Rasch methodology allowed 
obtaining a questionnaire which responses will be a trade-off between respondent’s 
abilities and item difficulty. Rasch assesses the appropriateness of item responses 
with probability curves that must appear ordered as the response categories. 
Overlapped categories suggested excess of response options and were reduced and 
items with disordered categories were eliminated. The goodness of fit of items in the 
Rasch model was calculated using the normalized Infit and Outfit statistics whose 
interval of good fit is (-2, 2). Items with statistics falling outside that interval were 
removed. Analyses were performed on a sample of 140 patients. Results: 55.0% of 
patients were men, aged 63.0 (mean)(SD:9.6) years. Patients had 14.6 (mean)(SD:6.9) 
years of T2DM duration and 5.5 (mean)(SD:11.1) hypoglycemias in the previous 
6 months. 11 items were deleted because of floor and ceiling effect. Most of probabil-
ity curves showed overlapping response categories; therefore two pairs of categories 
were joined. Probability curves were represented again and 11 items that showed 
disordered categories were eliminated. Goodness of fit of the 15 remaining items 
showed only 2 items not adjusting to the model that were deleted. The final version 
of QolHypo consisted of 13 items with 3 response categories. cOnclusiOns: Rasch 
analysis has led to obtain a reduced questionnaire for measuring how hypoglycemia 
affects the HRQoL in T2DM patients.
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Objectives: Diabetic foot ulcer (DFU) is a common complication of diabetes and 
not only an important factor of mortality among patients with diabetes but also 
a cause of decreased quality of life. The Diabetic Foot Ulcer Scale (DFS) and short 
form of the DFS (DFS-SF) provide comprehensive measurement of the impact of 
diabetic foot ulcers on patients’ QoL. The purpose of this study was to translate 
DFS-SF into Polish and evaluate its psychometric performance in patients with 
diabetic foot ulcers. MethOds: DFS-SF translation process was performed in line 
with Principles of Good Practice for the Translation and Cultural Adaptation Process 
for PROMs developed by ISPOR TCA group. Assessment of the reliability and valid-
ity of Polish DFS-SF was performed in native Polish patients with current DFU. The 
severity of ulcers was evaluated using the PEDIS scale. For each scale, the item 
convergent validity and discriminant validity was computed. Internal consistency 
of each subscale was examined using the Cronbach’s alpha coefficient. Inter-scale 
validity was examined by Spearman’s rank correlation coefficient between DFS-SF 
and SF-36v2. Results: The DFS-SF validation study involved 212 patients diagnosed 
with DFU, with 4.4 years of DFU duration on average. The average ulcer size was 
7.0 sq cm, and generally only one limb was affected. Men (72%) and type 2 diabetes 
patients (86%) prevailed, with 17.8 years representing the mean time since diagnosis. 
The mean population age was 62.5 years. The internal consistency of all scales of the 
Polish DFS-SF was high (Cronbach’s alpha ranged from 0.83 to 0.94). Item convergent 
and discriminant validity was satisfactory (median corrected item-scale correlation 
ranged from 0.61 to 0.81). The Polish DFS-SF demonstrated good construct validity 
when correlated with the SF-36v2. cOnclusiOns: The newly translated Polish 
DFS-SF may be used to assess the impact of DFU on HRQoL in Polish patients.
correct knowledge and positive attitude especially when they are faced with an 
emergence of chronic diseases. The aim of this study therefore is to assess the 
level of Type 2 Diabetes Mellitus (T2DM) awareness and disease related attitude 
among general population at Bujang Valley, Merbok, Kedah, Malaysia. MethOds: 
A questionnaire based, cross sectional study was conducted. The Diabetes Attitude 
Scale was used to assess the knowledge and attitude of respondents towards 
T2DM. Data was described descriptively and SPSS v.22 was used for data analy-
sis. Results: Out of three hundred and seventy seven respondents, major-
ity of the respondents (n= 156, 41.4%) were in age group of more than 40 years 
old and the cohort was dominated by Malay ethnic group. Females subjugated 
over males (n= 229, 60.7%) and the highest number of respondents were work-
ing as businessman (n= 115, 30.5%). Corresponding to the marital status, major-
ity of the respondent were married (n= 247, 65.5%). Majority of the respondents 
(n= 274, 72.7%) were reported as healthy with no chronic disease. The respond-
ents reported certain misapprehensions where they believed that T2DM have 
lesser complications, blood glucose control is needed for Type 1 Diabetes Mellitus 
only and the emotional effects of T2DM are minor. cOnclusiOns: The study 
reported insufficient level of knowledge among the respondents in management 
of T2DM. General population needs to have good collaboration with healthcare 
professionals to get more education and knowledge related to T2DM for their 
empowerment.
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Objectives: A small but growing body of evidence suggests that acute post-prandial 
hyperglycaemia (PPHG) can have a significant impact on some people with diabetes. 
This study was designed to develop a standardised tool to measure the impact of 
PPHG episodes. MethOds: Twenty-four adults (≥ 18 yrs) with Type 1 (n= 14) and 
Type 2 (n= 10) insulin-dependent diabetes took part in a qualitative study to describe 
the experience and impact of PPHG. Data were collected via one-to-one telephone 
interviews in the US (n= 10) and two focus groups in the UK (n= 14). Thematic analy-
sis was conducted on the transcripts to identify emerging themes. Themes were 
drawn into measurement domains and described in terms of specific items. The 
study protocol was approved by an ethics review board. Results: The qualita-
tive analysis identified 7 clear domains which could be grouped into two larger 
groups. The first 4 domains (25 items) relate to participants’ most recent spike 
in blood sugar within the last 2 weeks (How I felt; Thinking and Concentration; 
Work; Awareness). The remaining 3 domains (22 items) relate more generally to 
the experience of PPHG after eating (Preventative Behaviours; Worry and Concerns; 
Management). cOnclusiOns: The qualitative research identified a range of dif-
ferent ways that people can be affected by acute PPHG. This is reflected in the 
domains of the new measure. Further validation and testing is required and this 
is planned in a quantitative study involving 800 participants in the UK and US. 
This measure, when finalised, will allow us to better understand the impact and 
burden of acute PPHG.
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Objectives: Patient-reported outcomes is an effective way to evaluate risks/ben-
efits of antidiabetic treatment in patients with T2DM and has been increasingly 
considered in treatment decision-making. The goal of this multicenter observa-
tional study was to evaluate quality of life (QoL) and hypoglycemia burden in T2DM 
patients receiving oral combination therapy in a real-world setting. MethOds: A 
total of 160 T2DM patients receiving vildagliptin plus metformin (mean age 59.6 yrs; 
male/female 25/57) or sulphonylureas (SU) plus metformin (mean age 65.1 yrs; male/
female 23/55) for at least 6 months (mean 6.5 yrs, 0.6–17 yrs) were enrolled in the 
study. All the patients completed the QoL questionnaire SF-36 and the Hypoglycemia 
Perspectives Questionnaire. Integral QoL Index (IQoLI) was calculated on the basis 
of SF-36. Group comparisons were made using χ 2 test and analysis of covariance 
(ANCOVA) with adjustment for age, sex, disease duration, HbA1c level, complica-
tions, comorbidities. Results: Patients receiving SU plus metformin had worse 
role physical and role emotional functioning, vitality, social functioning and pain 
(p< 0.01) than those receiving vildagliptin plus metformin; their IQoLI was signifi-
cantly lower than in the latter group (p< 0.05). They exhibited more pronounced QoL 
impairment as compared to those receiving vildagliptin plus metformin (p= 0.002). 
50% patients on SU plus metformin vs 27% patients on vildagliptin plus metformin 
experienced hypoglycemia during the last 6 months (p< 0.003). In the group on SU 
plus metformin 9.6% patients had severe hypoglycemia and 4.1% – nocturnal hypo-
glycemia; patients on vildagliptin plus metformin – only non-severe hypoglycemia 
and no nocturnal hypoglycemia episodes. SU plus metformin therapy was accom-
panied with pronounced hypoglycemia burden as compared to vildagliptin plus 
metformin therapy. cOnclusiOns: Results of this real-world study demonstrate 
benefits of vildagliptin plus metformin combination therapy in T2DM patients as 
compared to SU plus metformin therapy in terms of better QoL and lower risks of 
treatment in terms of less hypoglycemia burden.
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on health related quality of life. Attention is needed to highlight determinants of 
health related quality of life and to implement policies for better management of 
Type 2 Diabetes Mellitus, particularly in early treatment phases where improving 
Health Related Quality of Life is still possible.
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Objectives: Diabetic foot ulcer (DFU) is a common complication of diabetes and 
not only an important factor of mortality among patients with diabetes but also 
decreases quality of life. Several clinical trials showed that patients with foot 
ulceration have significantly decreased HRQoL as compared to those without 
DFU. Most of these studies used SF-36 for quality of life measures, however it is 
suggested that the results of this HRQoL survey may be confounded by non-foot 
complications of diabetes. The short form of Diabetic Foot Ulcer Scale (DFS-SF) is 
a condition-specific tool, providing comprehensive measurement of DFU impact 
on patients’ QoL. The Polish translation of DFS-SF has undergone a full linguistic 
validation process and showed good psychometric performance in patients with 
DFU. The purpose of this study was to investigate the influence of ulcers healing 
process on HRQoL. MethOds: Assessment of healing process impact on HRQoL 
was performed in patients with active DFU. Wound healing assessment was car-
ried out on two control visits separated with a 6-months period, on the basis of 
wound diameter measurements and PEDIS score. Hypothesis testing was conducted 
using the Student’s t-test (α = 0.05). Results: Data on 120 patients were analyzed 
(mean age: 61.1 years, male: 73%, type 2 diabetes: 87%). The average ulcer size on 
first visit was 5.6 sq cm, and reduced significantly to 2.7 sq cm on second visit. 
Improvement in all six DFS-SF subscales was observed, statistically significant in 
physical health, worried about ulcers/feet and bothered by ulcer care subscales. 
Complete ulcer healing was observed in 42 patients. All six DFS-SF subscales showed 
greater improvement in this subpopulation compared to population without com-
plete ulcer healing, although the difference was not significant. cOnclusiOns: 
In previous study we identified weak negative correlation between ulcer size and 
HRQoL. This study showed that ulcers healing process has significant impact on 
HRQoL of DFU patients.
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Objectives: Understanding immediate improvements in health related quality-
of-life (HRQoL) due to better glycaemic control may help inform decisions relating 
to the management of diabetes. This study investigated the short-term impact on 
HRQoL associated with HbA1c change, body weight change, and the complexity of 
treatment regimen, using time-trade-off (TTO) methodology MethOds: The study 
was performed in three stages: 1) Qualitative telephone interviews with people 
with type 2 diabetes (T2D) in Denmark who experienced a decrease in their HbA1c 
level; 2) A validation survey with people with T2D in Denmark to obtain quantifiable 
knowledge on the short-term effects of a change in HbA1c levels; 3) TTO survey using 
health states based on results from stage 2. ‘Not well-controlled diabetes’ reflected 
an HbA1c average of 11.6%, and ‘well-controlled diabetes’ an HbA1c average of 
7.4%. All other health states were based on ‘well-controlled diabetes’. These health 
states implied change in insulin regimen and change in weight. Respondents were 
either adults with T2D (Sweden) or from the general public (UK and Denmark) and 
were separately randomly allocated to evaluate 6 of the 10 health states through an 
internet-based survey. Results: In total, 4060respondents were available for analy-
sis (UK n= 1777; Denmark n= 1799, Sweden n= 484). ‘Well-controlled diabetes’ was 
associated with a utility of 0.85-0.91 and ‘not well-controlled diabetes’ with utilities 
of 0.71-0.80. The treatment regimen health state associated with the smallest reduc-
tion in utility was the once-daily insulin regimen. As expected, results in all three 
countries suggested that respondents would prefer to lose rather than gain weight 
(utility of 0.87–0.92 for losing 5 kg and 0.88–0.92 for losing 2 kg). cOnclusiOns: A 
simple treatment regimen with fewer injections that improves HbA1c levels, avoids 
weight gain, or even causes weight loss, compared with other treatments, will have 
a positive impact on HRQoL.
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Objectives: The aim of this study was to estimate willingness to pay (WTP) amount 
for one quality adjusted-life years (QALY) in diabetic patients and investigating fac-
tors that associated with it. MethOds: A cross sectional survey with face to face 
interviews was conducted with diabetic patients in Tehran city between June and 
August of 2014 to elicit WTP for QALY as following: First, Current health preferences 
were measured using EuroQol-5D (EQ-5D), visual analogue Scale (VAS) and time 
trade off (TTO) techniques, then a hypothetical scenario using double bounded 
dichotomous choice technique was presented to patients to elicit individual’s maxi-
mum WTP for a treatment that recovering them to full health ,contingent to be 
available. finally, value of QALY was estimated by combining preferences. A regres-
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Objectives: Last few years there is drastic increase in type 2 DM cases especially in 
India. Quality of life is considered as one of the better assessment for management 
of diabetes in recent years. The main objective of the study was to assess the HRQOL 
among the diabetes patients using the EQ-5D (kannada version) and to correlate 
with patient demography, complications and treatment. MethOds: The study was 
carried out in medicine Out Patient Department of a tertiary care hospital for the 
period of 6 months. Patients who have fulfilled the inclusion criteria were enrolled 
in the study and demographical details like name, age, sex, occupation, and medical 
and medication history were collected from the medical record. Patients were inter-
viewed and EQ-5D-3L questionnaire was administered. Data was analysed using 
SPSS ver 20.0. Results: Total of 120 patients were selected as per the inclusion 
criteria, among them majority were males (60% N-72) and mean age was 56.8±10.3 
years.The mean value of TTO and VAS was 0.707± 0.2 and 0.688± 0.16 respectively. 
There was statistically significant relationship between HbA1c level and EQ-5D 
score (p< 0.05). Patients suffering from HTN and cardiovascular complications have 
lower EQ-5D scores than the mean scores, and was statistically significant for HTN 
(p< 0.05). There was significant relationship between EQ-5D score and the presence 
of neuropathy and retinopathy (p< 0.05). Patients with increased number of sub-
jective symptoms such as lethargy, fatigue, body pain, weight loss etc. have lower 
EQ-5D scores (p< 0.05). cOnclusiOns: We observed age wise increase in prevalence 
of diabetes mainly in males. Patient with increased age, increased HbA1C levels, 
presence of complications and increased number of diabetic symptoms showed 
increased problems with different dimensions of EQ-5D. We also observed increased 
age, increased HBA1C, presence of complications and increased number of diabetes 
symptoms will decrease the TTO and VAS scores.
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bAckgROund: Previous studies in patients with primary adrenal insufficiency (PAI) 
on conventional replacement therapy suggest decreased health-related quality of 
life (HRQoL), and that patients report more frequently fatigue, increased anxiety 
and inability to work compared to background population. Objectives: To study 
self-reported health status with EQ-5D in patients with PAI. Patients treated with 
Plenadren (modified-release hydrocortisone) were compared with patients treated 
with immediate release hydrocortisone (IRHC) replacement therapy. MethOds: 
This was a cross-sectional, multi-centre, non-interventional survey of patients 
with PAI receiving Plenadren or immediate release hydrocortisone (IRHC) replace-
ment. subjects: One hundred thirty-four adult patients with PAI of whom 
36 (19 females [53%]) were treated with Plenadren and 98 (77 females [79%]) were 
treated with IRHC, were included. MAin OutcOMe MeAsuRe: HRQoL described 
by the EQ-5D, a generic preference-based measure of health. Results: Patients 
on Plenadren and on IRHC had a mean ± SD age of 53.1 ± 12.7 years and 48.0 ± 13.1 
years, respectively (P= 0.043). The majority of the patients were diagnosed more 
than 5 years ago (69%). The mean ± SD daily Plenadren and IRHC doses were 27.0 ± 
6.8 mg and 26.6 ± 10.9 mg, respectively (P= 0.807). 47% of the Plenadren patients had 
been receiving Plenadren and 82% of the IRHC patients had been receiving IRHC 
for more than 3 years. Patients receiving Plenadren had better HRQoL measured 
by the EQ-5D questionnaire compared to patients replaced with IRHC (0.76 ± 0.18 
vs 0.68 ± 0.18, respectively [P= 0.040]). cOnclusiOns: Replacement therapy with 
Plenadren in patients with PAI confers measurable benefit on HRQoL relative to 
IRHC as estimated by the EQ-5D questionnaire, and may therefore be advantageous 
when compared to IRHC substitution.
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Objectives: This study was aimed to describe the Health Related Quality of 
Life profile of Type 2 Diabetes Mellitus population attending outpatient clinics in 
Pakistan. MethOds: The study was designed as a cross-sectional descriptive sur-
vey. Type 2 diabetic patients attending a tertiary care institute in Sargodha, Pakistan 
were targeted for the study. The EuroQol EQ-5D was used for the assessment of 
Health Related quality of Life and was scored using values derived from the UK 
general population survey. Descriptive statistics were used for the elaboration 
of socio-demographic characteristics. The chi-square test was used to depict the 
possible association between study variables and Health Related Quality of Life. 
Where significant associations were noted, Phi and Cramer’s V constant were used 
for data interpretation accordingly. P < 0.05 was taken as significant. Results: 
Three hundred and ninety two patients were approached for the study. The 
cohort was dominated by males (n= 222, 56.60 %) with 5.58±4.09 years of history 
of Type 2 Diabetes Mellitus. The study highlighted poor Health related Quality of 
Life among patients with Type 2 Diabetes Mellitus (0.471 ± 0.336). Gender, marital 
status, education, monthly income, occupation, location and duration of the dis-
ease was reported to be significantly associated with Health Related Quality of 
Life (P< 0.001). cOnclusiOns: Type 2 Diabetes Mellitus imposes a negative effect 
